REQUEST A DEMO
Total
USD $0.00
Search more companies

Medrock Corp. S.A.C. (Peru)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Medrock Corp. S.A.C. Profile Updated: February 24, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Medrock Corporation S.A.C. is a Peruvian company, incorporated in 13/12/2006. It is headquartered in the city of Lima and is engaged in Manufacture of pharmaceuticals, medicinal chemicals and botanical products.

Headquarters
Av. Bolivar 795, Pueblo Libre
Lima; Lima;

Contact Details: Purchase the Medrock Corp. S.A.C. report to view the information.

Website: http://www.medrocklab.com/

Basic Information
Total Employees:
Purchase the Medrock Corp. S.A.C. report to view the information.
Outstanding Shares:
Purchase the Medrock Corp. S.A.C. report to view the information.
Registered Capital:
Purchase the Medrock Corp. S.A.C. report to view the information.
Financial Auditors:
Purchase the Medrock Corp. S.A.C. report to view the information.
Incorporation Date:
December 13, 2006
Key Executives
Purchase this report to view the information.
President of the Board Directors
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Technical Manager
Purchase this report to view the information.
Quality Control Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Medrock Corp. S.A.C. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PEN. Absolute financial data is included in the purchased report.
Net sales revenue
-34.62%
Total operating revenue
3.85%
Operating profit (EBIT)
-51.65%
EBITDA
62.3%
Net Profit (Loss) for the Period
85.43%
Total assets
-9.29%
Total equity
-11.93%
Operating Profit Margin (ROS)
-3.94%
Net Profit Margin
2.95%
Return on Equity (ROE)
1.2%
Debt to Equity Ratio
-7.8%
Quick Ratio
-0.21%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?